To evaluate predictors of contralateral breast cancer risk, we examined data from a nested case-control study of second primary cancers among a cohort of women in western Washington (United States) diagnosed with breast cancer during 1978 through 1990 and identified through a population-based cancer registry. Cases included all women in the cohort who subsequently developed contralateral breast cancer at least six months after the initial diagnosis, but prior to 1992 (n=234). Controls were sampled randomly from the cohort, matched to cases on age, stage, and year of initial breast cancer diagnosis. Information on potential risk factors for second primary cancer was obtained through medical record abstractions and physician questionnaires. Women who were postmenopausal due to a bilateral oophorectomy (i.e., a surgical menopause) at initial breast cancer diagnosis had a reduction in contralateral breast cancer risk compared with premenopausal women (matched odds ratio [mOR]=0.25, 95 percent confidence interval [CI]=0.09–0.68), whereas no reduction in risk was noted among postmenopausal women who had had a natural menopause (mOR=0.90, CI=0.39–2.09). Among postmenopausal women, there was a suggestion of a lower risk associated with relatively high parity (2+). A family history of breast cancer was associated with an increased risk (mOR=1.96, CI=1.22–5.15) and varied little by menopausal status. Having an initial tumor with a lobular component (c.f. a ductal histology) was not related strongly to risk (mOR=1.47, CI=0.79–2.74). The results of the present and earlier studies argue that we have limited ability to predict the occurrence of a contralateral breast tumor. Better predictors will be required before diagnostic and preventive interventions can be targeted to subgroups of patients with unilateral breast cancer.
Similar content being viewed by others
References
Schottenfeld D, Berg J. Incidence of multiple primary cancers. IV. Cancer of the female breast and genital organs. JNCI 1971; 46: 161–70.
Murakami R, Hiyama T, Hanai A, Fujimoto I. Second primary cancers following female breast cancer in Osaka, Japan — a population-based cohort study. Jpn J Clin Oncol 1987; 17: 293–302.
Hislop TG, Elwood JM, Coldman AJ, et al. Second primary cancers of the breast: incidence and risk factors. Br J Cancer 1984; 49: 79–85.
Robbins GF, Berg JW. Bilateral primary breast cancers: A prospective clinicopathological study. Cancer 1964; 17: 1501–27.
Fisher ER, Fisher B, Sass R, Wickerham L, Collaborating NSABP Investigators. Pathological findings from the national surgical adjuvant breast project (protocol no. 4). Cancer 1984; 54: 3002–11.
Chaudary MA, Millis RR, Bulbrook RD, Hayward JL. Family history and bilateral primary breast cancer. Breast Cancer Res Trtmt 1985; 5: 201–5.
Bernstein JL, Thompson WD, Risch N, Holford TR. The genetic epidemiology of second primary breast cancer. Am J Epidemiol 1992; 136: 937–48.
Kato I, Miura S, Yoshida M, Tominaga S. Risk factors of multiple primary cancers in breast cancer patients. Jpn J Cancer Res 1986; 77: 296–304.
Horn P, Thompson WD. Risk of contralateral breast cancer: associations with factors related to initial breast cancer. Am J Epidemiol 1988; 128: 309–23.
Boice JDJr, Harvey EB, Blettner M, et al. Cancer in the contralateral breast after radiotherapy for breast cancer. New Engl J Med 1992; 326: 781–5.
Bernstein JL, Thompson WD, Risch N, Holford TR. Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. Am J Epidemiol 1992; 136: 925–36.
Horn PL, Thompson WD. Risk of contralateral breast cancer: associations with histologic, clinical, and therapeutic factors. Cancer 1988; 62: 412–24.
Horn PL, Thompson WD, Schwartz SM. Factors associated with the risk of second primary breast cancer: an analysis of data from the Connecticut tumor registry. J Chron Dis 1987: 40: 1003–11.
Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cyctotoxic, or immune therapy. Lancet 1992; 339: 1–15.
Horn PL, Thompson WD. Exposure to chemotherapeutic agents and the risk of a second breast cancer: preliminary findings. Yale J Biol Med 1988; 61: 223–31.
Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cyctotoxic, or immune therapy. Lancet 1992; 339: 71–85.
Arriagada R, Rutqvist LE. Adjuvant chemotherapy in early breast cancer and incidence of new primary malignancies. Lancet 1991; 338: 535–8.
Cook LS, Weiss NS, Schwartz SM, et al. A population-based study of tamoxifen therapy for breast cancer and subsequent ovarian, endometrial, and breast cancer. JNCI 1995; 87: 1359–64.
Daling JR, Malone KE, Voigt LF, et al. Risk of breast cancer among young women: relationship to induced abortion. JNCI 1994; 86: 1584–92.
Stanford JL, Weiss NS, Voigt LF, et al. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA, in press.
The Centers for Disease Control. Long-term oral contraceptive use and the risk of breast cancer. JAMA 1983; 249: 1591–5.
Armstrong BK, White E, Saracci R. Principles of Exposure Measurement in Epidemiology. New York, NY (USA): Oxford University Press, 1992; Monogr Epi Biostat.
Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol. I. The Analysis of Case-control Studies. Lyon, France: International Agency for Research on Cancer, 1980; IARC Sci. Pub. No. 32.
Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research. Principles and Quantitative Methods. New York, NY (USA): Van Nostrand Reinhold, 1982.
Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993; 15: 36–47.
Horn-Ross PL. Multiple primary cancers involving the breast. Epidemiol Rev 1993; 15: 169–75.
Storm HH, Andersson M, Boice JDJr, et al. Adjuvant radiotherapy and risk of contralateral breast cancer. JNCI 1992; 84: 1245–50.
Burns PE, Dabbs K, May C, et al. Bilateral breast cancer in northern Alberta: risk factors and survival patterns. Can Med Assoc J 1984; 130: 881–6.
Hunter DJ, Willett WC. Diet, body size, and breast cancer. Epidemiol Rev 1993; 15: 110–32.
Lindblom A. Familial breast cancer and genes involved in breast carcinogenesis. Breast Cancer Res Trtmt 1995; 34: 171–83.
Slattery ML, Kerber RA. A comprehensive evaluation of family history and breast cancer risk. JAMA 1993; 270: 1563–8.
Kelsey JL. Breast cancer epidemiology: summary and future directions. Epidemiol Rev 1993; 15: 256–63.
Dixon JM, Anderson TJ, Page DL et al. Infiltrating lobular carcinoma of the breast: an evaluation of the incidence and consequence of bilateral disease. Br J Surg 1983; 70: 513–6.
Hankey BF, Curtis RE, Naughton MD, et al. A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy. JNCI 1983; 70: 797–804.
Frass BA, Roberson PL, Lichter AS. Dose to the contralateral breast due to primary breast irradiation. Int J Rad Oncol Biol Phys 1985; 11: 485–97.
Additional information
Authors are with the Department of Epidemiology, University of Washington, Seattle, WA, USA (Drs Cook, White, Schwartz, Daling, Weiss); with the Fred Hutchinson Cancer Research Center, Seattle, WA (Drs Cook, White, Schwartz, McKnight, Daling, Weiss); and the Department of Biostatistics, University of Washington, Seattle, WA (Dr McKnight). Address correspondence to Dr Cook, MP-381, Fred Hutchinson Cancer Research Center, 1124 Columbia Street, Seattle, WA 98104, USA. This research was supported in part by grants from the US National Cancer Institute (R35 CA 39779), the Agency for Health Care Policy and Research (1 RO3 HS08004-01), and by the Cancer Surveillance System of the Fred Hutchinson Cancer Research Center, which is funded by Contract No. N01-CN-05230 from the Surveillance, Epidemiology and End Results (SEER) program of the National Cancer Institute with additional support from the Fred Hutchinson Cancer Research Center.
Rights and permissions
About this article
Cite this article
Cook, L.S., White, E., Schwartz, S.M. et al. A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States). Cancer Causes Control 7, 382–390 (1996). https://doi.org/10.1007/BF00052945
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00052945